Ottawa, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The global pelvic inflammatory disease treatment market size was valued at USD 3.52 billion in 2024 and is predicted to hit around USD 5.09 billion by 2034, ...

Every time Erin publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from Business ...

Although someone can get pelvic inflammatory disease from using an intrauterine device (IUD), the risk is very low. The incidence is less than 1%. The above information comes from a 2018 study. Pelvic ...

November 14, 2011 — Recurrent pelvic inflammatory disease (PID) is associated with an increased risk for infertility and chronic pelvic pain (CPP), according to a study published in the September ...

Vaginal infections can be divided into bacterial, fungal, and parasitic infections based on their causative pathogens. The excellent properties of hydrogels include many key properties such as ...

Since women with PID present with varying signs and symptoms, the diagnosis and management of PID is not straightforward. In the case of silent PID, women have mild or no pelvic pain, despite evidence ...

PID is an infection of the female reproductive organs. It’s often the result of an untreated sexually transmitted infection (STI). Yeast infections are not considered a contributing factor. “Yeast ...

Fitz-Hugh-Curtis syndrome (FHCS) is a rare complication of pelvic inflammatory disease (PID). FHCS occurs almost exclusively in females and can cause abdominal pain, fever, and malaise. FHCS describes ...

That mild cramping you’ve been brushing off as “just another bad period” might actually be your body sending an urgent message. Those subtle symptoms you’re tempted to ignore could be signaling a ...

Pelvic inflammatory disease (PID), the infection and inflammation of the female genital tract, results in serious reproductive morbidity including infertility and ectopic pregnancy. Bacterial ...

About 9% of patients with inborn errors of immunity/primary immune disorders developed cancer, especially B-NHL, a European study found.

(MENAFN- GlobeNewsWire - Nasdaq) The global pelvic inflammatory disease treatment market size is calculated at USD 3.65 billion in 2025 and is expected to reach around USD 5.09 billion by 2034, ...